She points to work shown at ADA 2026 and published in Nature Communications suggesting semaglutide may improve epigenetic aging markers.
Recap by typeshit. Post by @dramagdalenafarias on Instagram.
Observational data link GLP-1 drugs to fewer cases of some cancers, but trials have yet to show they prevent cancer or help survival after a diagnosis.
Weight loss may explain much of the knee benefit, but lab work hints at anti-inflammatory and cartilage effects worth a closer read.
A new GLP-1 described as stronger than current options is being tested in trials, and researchers lay out what people should understand about it.
He points to a randomized clinical trial where the P11-4 peptide was tested for helping teeth rebuild mineral. Results are his to describe.
Consumer Reports scored frozen meals on nutrition and taste as brands push high protein and GLP-1 friendly claims on the box.
Access to Ozempic, Wegovy and Mounjaro in Australia often comes down to who can pay, raising the question of public subsidies.
Loading…